Oligonucleotide API Manufacturing
Accelerate Your Journey from Clinical to Market
Partnering with Agilent, an experienced contract development and manufacturing organization, will give you the confidence that your clinical and commercial oligonucleotide API will meet appropriate specifications, quality, and purity requirements.
In two state-of-the art cGMP facilities in Colorado, U.S., Agilent produces grams to kilograms of siRNA, antisense, aptamers, gRNA, and other oligos. We are expanding capacity to take on more programs, increase batch sizes, and address our partners’ needs more quickly.
Agilent supports six commercial programs; you can rely on our expertise throughout clinical trials and commercialization. Accelerate speed to clinic and market, scale chemical processes, and produce high-quality oligo API with us.
In two state-of-the art cGMP facilities in Colorado, U.S., Agilent produces grams to kilograms of siRNA, antisense, aptamers, gRNA, and other oligos. We are expanding capacity to take on more programs, increase batch sizes, and address our partners’ needs more quickly.
Agilent supports six commercial programs; you can rely on our expertise throughout clinical trials and commercialization. Accelerate speed to clinic and market, scale chemical processes, and produce high-quality oligo API with us.
